Soluble amyloid β-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls
- 1 December 1994
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 127 (1), 90-95
- https://doi.org/10.1016/0022-510x(94)90140-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Soluble Amyloid β-Protein Is a Marker of Alzheimer Amyloid in Brain But Not in Cerebrospinal FluidBiochemical and Biophysical Research Communications, 1994
- Isolation and quantification of soluble Alzheimer's β-peptide from biological fluidsNature, 1992
- Analysis and Quantitation of the β‐Amyloid Precursor Protein in the Cerebrospinal Fluid of Alzheimer's Disease Patients with a Monoclonal Antibody‐Based ImmunoassayJournal of Neurochemistry, 1991
- Expression of human Alzheimer amyloid precursor protein in insect cellsBiochemical and Biophysical Research Communications, 1991
- Detection of soluble forms of the β-amyloid precursor protein in human plasmaBiochemical and Biophysical Research Communications, 1990
- Detection of amyloid beta protein precursor immunoreactivity in normal and Alzheimer's disease cerebrospinal fluidLife Sciences, 1989
- Soluble derivatives of the β amyloid protein precursor of Alzheimer's disease are labeled by antisera to the β amyloid proteinBiochemical and Biophysical Research Communications, 1989
- Alzheimer's disease amyloid precursor protein is present in senile plaques and cerebrospinal fluid: Immunohistochemical and biochemical characterizationBiochemical and Biophysical Research Communications, 1989
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982